{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T18:14:22Z","timestamp":1778696062438,"version":"3.51.4"},"reference-count":50,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2020,1,13]],"date-time":"2020-01-13T00:00:00Z","timestamp":1578873600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0226495","type":"journal-article","created":{"date-parts":[[2020,1,13]],"date-time":"2020-01-13T18:34:57Z","timestamp":1578940497000},"page":"e0226495","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":17,"title":["Radioiodine therapy and Graves\u2019 disease \u2013 Myths and reality"],"prefix":"10.1371","volume":"15","author":[{"given":"Maria Teresa","family":"Plazinska","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadia","family":"Sawicka-Gutaj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agata","family":"Czarnywojtek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9800-7881","authenticated-orcid":true,"given":"Kosma","family":"Wolinski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ma\u0142gorzata","family":"Kobylecka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Karli\u0144ska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karolina","family":"Prasek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ma\u0142gorzata","family":"Zgorzalewicz-Stachowiak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magdalena","family":"Borowska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pawe\u0142","family":"Gut","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marek","family":"Ruchala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leszek","family":"Krolicki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2020,1,13]]},"reference":[{"key":"pone.0226495.ref001","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S0140-6736(03)14073-1","article-title":"Hyperthyroidism","volume":"362","author":"DS Cooper","year":"2003","journal-title":"Lancet"},{"key":"pone.0226495.ref002","doi-asserted-by":"crossref","first-page":"2594","DOI":"10.1056\/NEJMcp0801880","article-title":"Clinical practice. Graves' disease","volume":"358","author":"GA Brent","year":"2008","journal-title":"N Engl J Med"},{"key":"pone.0226495.ref003","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.mce.2010.01.013","article-title":"Genetics of thyroid autoimmunity and the role of the TSHR","volume":"322","author":"OJ Brand","year":"2010","journal-title":"Mol Cell Endocrinol"},{"key":"pone.0226495.ref004","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1089\/thy.2010.0059","article-title":"A novel bioreporter assay for thyrotropin receptor antibodies using a chimeric thyrotropin receptor (mc4) is more useful in differentiation of Graves' disease from painless thyroiditis than conventional thyrotropin-stimulating antibody assay using porcine thyroid cells","volume":"20","author":"K Kamijo","year":"2010","journal-title":"Thyroid"},{"key":"pone.0226495.ref005","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1210\/er.2002-0020","article-title":"Current perspective on the pathogenesis of Graves`disease and ophthalmopathy","volume":"24","author":"BS Prabhakar","year":"2003","journal-title":"Endocrine Reviews"},{"key":"pone.0226495.ref006","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1056\/NEJMcp0806317","article-title":"Clinical practice. Graves' ophthalmopathy","volume":"360","author":"L Bartalena","year":"2009","journal-title":"N Engl J Med"},{"key":"pone.0226495.ref007","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1210\/jc.2012-3873","article-title":"Prevalence and natural history of Graves' orbitopathy in a large series of patients with newly diagnosed Graves' hyperthyroidism seen at a single center","volume":"98","author":"ML Tanda","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"pone.0226495.ref008","first-page":"444","article-title":"Prevalence and natural history of Graves' orbitopathy in the XXI century","volume":"36","author":"E Piantanida","year":"2013","journal-title":"J Endocrinol Invest"},{"issue":"1","key":"pone.0226495.ref009","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1159\/000443828","article-title":"The 2016 European Thyroid Association\/European Group on Graves' Orbitopathy Guidelines for the Management of Graves' Orbitopathy","volume":"5","author":"L Bartalena","year":"2016","journal-title":"Eur Thyroid J"},{"key":"pone.0226495.ref010","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1056\/NEJM200010263431707","article-title":"Graves' disease","volume":"343","author":"AP Weetman","year":"2000","journal-title":"N Engl J Med"},{"key":"pone.0226495.ref011","first-page":"1010","article-title":"Risk factors influence on Graves' disease and Graves' ophthalmopathy","volume":"68","author":"A Czarnywojtek","year":"2011","journal-title":"Przegl Lek"},{"key":"pone.0226495.ref012","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1210\/jc.2006-1824","article-title":"Smoking and thyroid-associated ophthalmopathy: A novel explanation of the biological link","volume":"92","author":"TJ Cawood","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"pone.0226495.ref013","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1136\/bjo.87.6.773","article-title":"Impact of smoking on the response to treatment of thyroid associated ophthalmopathy","volume":"87","author":"A Eckstein","year":"2003","journal-title":"Br J Ophthalmol"},{"key":"pone.0226495.ref014","doi-asserted-by":"crossref","first-page":"3700","DOI":"10.1210\/jc.2009-0747","article-title":"Thyroid-associated ophthalmopathy after treatment for Graves' hyperthyroidism with antithyroid drugs or iodine-131","volume":"94","author":"F Tr\u00e4isk","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"pone.0226495.ref015","first-page":"978","article-title":"Radioiodine-induced hypothyroidism in Graves\u2019 disease: factors associated","volume":"23","author":"AJ Cunnien","year":"1982","journal-title":"J Nucl Med"},{"key":"pone.0226495.ref016","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1111\/j.1365-2796.1994.tb00837.x","article-title":"Standardized radioiodine therapy in Graves\u2019 disease: the persistent effect of thyroid weight and radioiodine uptake on outcome","volume":"236","author":"TW de Bruin","year":"1994","journal-title":"J Intern Med"},{"key":"pone.0226495.ref017","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.arcmed.2006.09.007","article-title":"Radioiodine treatment in autoimmune hyperthyroidism: analysis of outcomes in relation to dosage","volume":"38","author":"S Hernandez-Jim\u00e9nez","year":"2007","journal-title":"Arch Med Res"},{"key":"pone.0226495.ref018","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1586\/17512433.2016.1165606","article-title":"Advances in the pharmacological treatment of Graves\u2019 orbitopathy","volume":"9","author":"M Rucha\u0142a","year":"2016","journal-title":"Expert review of clinical pharmacology"},{"key":"pone.0226495.ref019","first-page":"330","article-title":"Thyroid ultrasound\u2014a piece of cake?","volume":"61","author":"M Rucha\u0142a","year":"2011","journal-title":"Endokrynol Pol"},{"key":"pone.0226495.ref020","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1530\/EJE-07-0450","article-title":"TSH-receptor autoimmunity in Graves' disease after therapy with anti-thyroid drugs, surgery, or radioiodine: a 5-year prospective randomized study","volume":"158","author":"P Laurberg","year":"2008","journal-title":"Eur J Endocrinol"},{"key":"pone.0226495.ref021","first-page":"10","article-title":"Correlation between thyroid volume and humoral thyroid autoimmunity after radioiodine therapy in Graves\u2019 disease","volume":"63","author":"N Sawicka","year":"2012","journal-title":"Endokrynol Pol"},{"key":"pone.0226495.ref022","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1111\/j.1365-2265.2008.03279.x","article-title":"Radioiodine therapy (RAI) for Graves' disease (GD) and the effect on ophthalmopathy: a systematic review","volume":"69","author":"SH Acharya","year":"2008","journal-title":"Clin Endocrinol (Oxf)"},{"key":"pone.0226495.ref023","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1089\/thy.2011.0362","article-title":"Evidence for higher success rates and successful treatment earlier in Graves\u2019 disease with higher radioactive iodine doses","volume":"22","author":"S Sztal-Mazer","year":"2012","journal-title":"Thyroid"},{"key":"pone.0226495.ref024","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1111\/j.1365-2265.2007.03097.x","article-title":"Pearce SH. Radioiodine treatment for benign thyroid disorders: results of a nationwide survey of UK endocrinologists","volume":"68","author":"B Vaidya","year":"2008","journal-title":"Clin Endocrinol (Oxf)"},{"key":"pone.0226495.ref025","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1007\/s00259-010-1536-8","article-title":"EANM procedure guidelines for therapy of benign thyroid disease","volume":"37","author":"MPM Stokkel","year":"2010","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"pone.0226495.ref026","first-page":"54","article-title":"Influence of cigarette smoking on thyroid gland\u2014an update","volume":"65","author":"N Sawicka-Gutaj","year":"2014","journal-title":"Endokrynol Pol"},{"key":"pone.0226495.ref027","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1530\/eje.0.1460153","article-title":"Smoking and thyroid disorders\u2013a meta-analysis","volume":"146","author":"P Vestergaard","year":"2002","journal-title":"Eur J Endocrinol"},{"key":"pone.0226495.ref028","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1055\/s-2006-924065","article-title":"Impact of smoking on the course of Graves\u2019 disease after withdrawal of antithyroid drugs","volume":"114","author":"B Quadbeck","year":"2006","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"pone.0226495.ref029","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1055\/s-0031-1285910","article-title":"The association of cigarette smoking with serum TSH concentration and thyroperoxidase antibody","volume":"120","author":"L Mehran","year":"2012","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"pone.0226495.ref030","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/j.1365-2265.2010.03790.x","article-title":"Interaction between cigarette smoking and iodine intake and their impact on thyroid function","volume":"73","author":"NH Cho","year":"2010","journal-title":"Clin Endocrinol (Oxf)"},{"key":"pone.0226495.ref031","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1001\/archinte.167.13.1428","article-title":"Tobacco smoking and thyroid function: a population-based study","volume":"167","author":"B Asvold","year":"2007","journal-title":"Arch Intern Med"},{"key":"pone.0226495.ref032","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1055\/s-2006-924264","article-title":"Serum TSH levels in smoking and non-smoking patients. The 5th Troms\u00f8 study","volume":"114","author":"R Jorde","year":"2006","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"pone.0226495.ref033","doi-asserted-by":"crossref","first-page":"6077","DOI":"10.1210\/jc.2004-0431","article-title":"Smoke exposure is associated with a lower prevalence of serum thyroid autoantibodies and thyrotropin concentration elevation and a higher prevalence of mild thyrotropin concentration suppression in the Third National Health and Nutrition Examination Survey (NHANES III)","volume":"89","author":"RM Belin","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"pone.0226495.ref034","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s10654-008-9255-1","article-title":"The impact of smoking on thyroid volume and function in relation to a shift towards iodine sufficiency","volume":"23","author":"P Vejbjerg","year":"2008","journal-title":"Eur J Epidemiology"},{"key":"pone.0226495.ref035","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1001\/archinte.162.4.439","article-title":"Association of tobacco smoking with goiter in a low-iodine intake area","volume":"162","author":"N Knudsen","year":"2002","journal-title":"Arch Intern Med"},{"key":"pone.0226495.ref036","first-page":"166","article-title":"Evaluation of radioiodine 131I treatment in Graves' disease patients with mild orbitopathy","volume":"66","author":"A Ba\u0142dys\u2013Walig\u00f3rska","year":"2009","journal-title":"Przegl Lek"},{"key":"pone.0226495.ref037","doi-asserted-by":"crossref","first-page":"4174","DOI":"10.1245\/s10434-014-3858-4","article-title":"Failure of radioactive iodine in the treatment of hyperthyroidism","volume":"21","author":"DF Schneider","year":"2014","journal-title":"Ann Surg Oncol"},{"key":"pone.0226495.ref038","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1210\/jc.2002-020805","article-title":"randomized comparison of radioiodine doses in Graves hyperthyroidism","volume":"88","author":"WD Leslie","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"pone.0226495.ref039","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1055\/s-2000-5807","article-title":"Radioiodine therapy in Graves hyperthyroidism: determination of individual optimum target dose","volume":"108","author":"A Haase","year":"2000","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"pone.0226495.ref040","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1007\/s002590100621","article-title":"Meller B, Richter E. Determination of the optimal minimum radioiodine dose in patients with Graves disease: a clinical outcome study","volume":"28","author":"D Howarth","year":"2001","journal-title":"Eur J Nucl Med"},{"key":"pone.0226495.ref041","first-page":"1073","article-title":"High dose of 131I therapy for the treatment of hyperthyroidism caused by Graves\u2019 disease","volume":"87","author":"EK Alexander","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"pone.0226495.ref042","doi-asserted-by":"crossref","first-page":"7","DOI":"10.4103\/1450-1147.98731","article-title":"Radioiodine Thyroid Ablation in Graves\u2019 Hyperthyroidism: Merits and Pitfalls","volume":"11","author":"JF Nwatsock","year":"2012","journal-title":"World J Nucl Med"},{"key":"pone.0226495.ref043","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1530\/EJE-07-0450","article-title":"TSH-receptor autoimmunity in Graves' disease after therapy with anti-thyroid drugs, surgery, or radioiodine: a 5-year prospective randomized study","volume":"158","author":"P Laurberg","year":"2008","journal-title":"Eur J Endocrinol"},{"key":"pone.0226495.ref044","first-page":"168","article-title":"Management of Graves' ophthalmopathy: reality and perspectives","volume":"21","author":"L Bartalena","year":"2000","journal-title":"Endocr Rev"},{"key":"pone.0226495.ref045","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1055\/s-0033-1363193","article-title":"Increased TRAb and\/or Low Anti-TPO Titers at Diagnosis of Graves\u2019 Disease are Associated with an Increased Risk of Developing Ophthalmopathy after Onset","volume":"122","author":"M Lantz","year":"2014","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"pone.0226495.ref046","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1038\/nrendo.2013.193","article-title":"Diagnosis and management of Graves\u2019 disease: a global overview","volume":"9","author":"L Bartalena","year":"2013","journal-title":"Nat Rev Endocrinol"},{"key":"pone.0226495.ref047","doi-asserted-by":"crossref","first-page":"746","DOI":"10.20452\/pamw.3505","article-title":"Efficacy and safety of radioiodine therapy for mild Graves ophthalmopathy depending on cigarette consumption: a 6-month follow-up","volume":"126","author":"A Czarnywojtek","year":"2016","journal-title":"Pol Arch Med Wewn"},{"key":"pone.0226495.ref048","doi-asserted-by":"crossref","first-page":"5497","DOI":"10.1210\/jc.2005-1553","article-title":"Editorial: glucocorticoids for Graves' ophthalmopathy: how and when","volume":"90","author":"L Bartalena","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"pone.0226495.ref049","doi-asserted-by":"crossref","first-page":"5321","DOI":"10.1210\/jc.2005-0507","article-title":"A prospective study of the effects of radioiodine therapy for hyperthyroidism in patients with minimally active Graves\u2019 ophthalmopathy","volume":"90","author":"P Perros","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"pone.0226495.ref050","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1055\/s-2006-924321","article-title":"Radioiodine Therapy of Graves' Hyperthyroidism in Patients Without Pre-existing Ophthalmopathy: Can Glucocorticoids Prevent the Development of New Ophthalmopathy?","volume":"114","author":"B Dederichs","year":"2006","journal-title":"Exp Clin Endocrinol Diabetes"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0226495","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,30]],"date-time":"2024-07-30T01:59:07Z","timestamp":1722304747000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0226495"}},"subtitle":[],"editor":[{"given":"Silvia","family":"Naitza","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2020,1,13]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,1,13]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0226495","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,13]]}}}